Trial Profile
"Effects of agomelatine (25 to 50 mg/day) on sleep EEG parameters compared to escitalopram in patients with Major Depressive Disorder.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Oct 2021
Price :
$35
*
At a glance
- Drugs Agomelatine (Primary) ; Escitalopram
- Indications Major depressive disorder
- Focus Pharmacodynamics
- 16 Jul 2007 New trial record.